Radical fimbriectomy: A reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 472-476

  Leblanc, Eric ^a   Narducci, Fabrice ^a   Farre, Isabelle ^a   Peyrat, Jean Philippe ^a   Taieb, Sophie ^a   Adenis, Claude ^a   Vennin, Philippe ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

BRCA1; BRCA2; Fimbriectomy; Prophylactic surgery; Salpingectomy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BILATERAL SALPINGOOOPHORECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE STERILIZATION; FIMBRIA; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; KIDNEY PELVIS CARCINOMA; OVARIECTOMY; OVARY CANCER; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RADICAL FIMBRIECTOMY; RISK REDUCTION; SAFETY; SALPINGOOOPHORECTOMY; SCALPEL; STAPLER; SURGICAL TECHNIQUE;

FALLOPIAN TUBES; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LAPAROSCOPY; OVARIAN NEOPLASMS; OVARY; SALPINGOSTOMY;

EID: 79957529938     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.012     Document Type: Article

References (38)

1. S.M. Domchek, J.E. Stopfer, and T.R. Rebbeck Bilateral risk-reducing oophorectomy in BRCA1 and BRCA2 mutation carriers J Natl Compr Canc Netw 4 2006 177 182 (Pubitemid 44265373)
2. J. Prat, A. Ribe, and A. Gallardo Hereditary ovarian cancer Hum Pathol 36 2005 861 870 (Pubitemid 41187904)
3. N.M. van der Velde, M.J. Mourits, H.J. Arts, J. de Vries, B.K. Leegte, and G. Dijkhuis Time to stop ovarian cancer screening in BRCA1/2 mutation carriers? Int J Cancer 124 2009 919 923
4. N.D. Kauff, S.M. Domchek, T.M. Friebel, M.E. Robson, J. Lee, and J.E. Garber Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study J Clin Oncol 26 2008 1331 1337
5. T.R. Rebbeck, N.D. Kauff, and S.M. Domchek Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers J Natl Cancer Inst 101 2009 80 87
6. S.M. Domchek, T.M. Friebel, C.F. Singer, D.G. Evans, H.T. Lynch, and C. Isaacs Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality JAMA 304 2010 967 975
7. A. Finch, P. Shaw, B. Rosen, J. Murphy, S.A. Narod, and T.J. Colgan Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers Gynecol Oncol 100 2006 58 64 (Pubitemid 41815050)
8. D.R. Semmel, A.K. Folkins, M.S. Hirsch, M.R. Nucci, and C.P. Crum Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria Mod Pathol 22 2009 985 988
9. ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy Obstet Gynecol 111 2008 231 241
10. L.C. Friedman, and R.M. Kramer Reproductive issues for women with BRCA mutations J Natl Cancer Inst Monogr 2005 83 86
11. T.M. Michelsen, A. Dorum, C.G. Trope, S.D. Fossa, and A.A. Dahl Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer Int J Gynecol Cancer 19 2009 1029 1036
12. A. Benshushan, N. Rojansky, M. Chaviv, S. Arbel-Alon, A. Benmeir, and T. Imbar Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy Climacteric 12 2009 404 409
13. M. Robson, M. Hensley, R. Barakat, C. Brown, D. Chi, and E. Poynor Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy Gynecol Oncol 89 2003 281 287 (Pubitemid 36457877)
14. C.M. Rivera, B.R. Grossardt, D.J. Rhodes, R.D. Brown Jr., V.L. Roger, and L.J. Melton 3rd Increased cardiovascular mortality after early bilateral oophorectomy Menopause 16 2009 15 23
15. W.A. Rocca, B.R. Grossardt, Y.E. Geda, B.S. Gostout, J.H. Bower, and D.M. Maraganore Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy Menopause 15 2008 1050 1059
16. W.H. Parker, M.S. Broder, E. Chang, D. Feskanich, C. Farquhar, and Z. Liu Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study Obstet Gynecol 113 2009 1027 1037
17. I. Cass, A. Walts, and B.Y. Karlan Does risk-reducing bilateral salpingo-oophorectomy leaved behind residual tube? Gynecol Oncol 117 2010 27 31
18. Y. Lee, F. Medeiros, D. Kindelberger, M.J. Callahan, M.G. Muto, and C.P. Crum Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer Adv Anat Pathol 13 2006 1 7 (Pubitemid 44357143)
19. F. Medeiros, M.G. Muto, Y. Lee, J.A. Elvin, M.J. Callahan, and C. Feltmate The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome Am J Surg Pathol 30 2006 230 236 (Pubitemid 43740193)
20. C.P. Crum, R. Drapkin, D. Kindelberger, F. Medeiros, A. Miron, and Y. Lee Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer Clin Med Res 5 2007 35 44 (Pubitemid 350218778)
21. J.T. Rabban, B. Crawford, L.M. Chen, C.B. Powell, and C.J. Zaloudek Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations Am J Surg Pathol 33 2009 111 119
22. A.K. Folkins, E.A. Jarboe, M.H. Roh, and C.P. Crum Precursors to pelvic serous carcinoma and their clinical implications Gynecol Oncol 113 2009 391 396
23. D. Cibula, M. Widschwendter, O. Majek, and L. Dusek Tubal ligation and the risk of ovarian cancer: review and meta-analysis Hum Reprod Update 2010
24. J.D. Seidman, A. Yemelyanova, R.J. Zaino, and R.J. Kurman The fallopian tube-peritoneal junction: a potential site of carcinogenesis Int J Gynecol Pathol 2010
25. R.J. Kurman, and IeM Shih The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory Am J Surg Pathol 34 2010 433 443
26. D. Botwell The genesis and evolution of high-grade serous ovarian cancer Nat Rev Cancer 10 2010 803 808
27. T.J. Colgan, J. Murphy, D.E. Cole, S. Narod, and B. Rosen Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status Am J Surg Pathol 25 2001 1283 1289 (Pubitemid 32917122)
28. P.J. Paley, E.M. Swisher, R.L. Garcia, S.N. Agoff, B.E. Greer, and K.L. Peters Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis Gynecol Oncol 80 2001 176 180 (Pubitemid 32158455)
29. J.T. Rabban, E. Krasik, L.M. Chen, C.B. Powell, B. Crawford, and C.J. Zaloudek Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol Am J Surg Pathol 33 2009 1878 1885
30. Y. Lee, A. Miron, R. Drapkin, M.R. Nucci, F. Medeiros, and A. Saleemuddin A candidate precursor to serous carcinoma that originates in the distal fallopian tube J Pathol 211 2007 26 35 (Pubitemid 46092026)
31. J.W. Carlson, A. Miron, E.A. Jarboe, M.M. Parast, M.S. Hirsch, and Y. Lee Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention J Clin Oncol 26 2008 4160 4165
32. J.D. Seidman, P. Zhao, and A. Yemelyanova "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer Gynecol Oncol 2010
33. M.H. Roh, D. Kindelberger, and C.P. Crum Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? Am J Surg Pathol 33 2009 376 383
34. E. Kuhn, A. Meeker, T.L. Wang, A.S. Sehdev, R.J. Kurman, and M. Shih Ie Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis Am J Surg Pathol 34 2010 829 836
35. N. Auersperg The origin of ovarian carcinoma: a unifying hyppothesis Int J Gynecol Pathol 30 2010 12 21
36. M.H. Greene, P.L. Mai, and P.E. Schwartz Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers? Am J Obstet Gynecol 2010
37. U. Menon, A. Gentry-Maharaj, R. Hallett, A. Ryan, M. Burnell, and A. Sharma Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 2009 327 340
38. S. Chen, and G. Parmigiani Meta-analysis of BRCA1 and BRCA2 penetrance J Clin Oncol 25 2007 1329 1333 (Pubitemid 46706879)